Health Canada Approves New 15-Day Glucose Monitoring System
Health Canada has officially authorized the Dexcom G7 15 Day Continuous Glucose Monitoring (CGM) system. This new medical device is designed for individuals aged 18 and older who are living with diabetes.
The G7 system is a small, wearable sensor that tracks glucose levels in real-time. By providing constant data, it helps patients manage their health more effectively without the need for frequent finger-prick tests.
This authorization is a significant step for Canadians managing diabetes. The 15-day wear time offers users a longer period of convenience compared to previous models, which typically required more frequent sensor changes.
Continuous glucose monitors have become an essential tool for many people to maintain stable blood sugar levels. By receiving this approval, the G7 system will soon be available to help adults across the country monitor their condition with greater ease and accuracy.
Patients interested in using the new system are encouraged to speak with their healthcare providers. Doctors can offer guidance on how this technology fits into their current diabetes management plan.